Crescent Biopharma, Inc. (CBIO)
18.51
+0.58
(+3.23%)
USD |
NASDAQ |
Sep 02, 16:00
18.51
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Debt to Equity Ratio : 0.0088 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0088 |
| March 31, 2026 | 0.0084 |
| December 31, 2025 | 0.0081 |
| September 30, 2025 | 0.0149 |
| June 30, 2025 | 0.0118 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.0126 |
| September 30, 2024 | 0.023 |
| June 30, 2024 | 0.0224 |
| March 31, 2024 | 0.0218 |
| December 31, 2023 | 0.021 |
| September 30, 2023 | 0.0217 |
| June 30, 2023 | 0.0232 |
| March 31, 2023 | 0.0105 |
| December 31, 2022 | 0.0214 |
| September 30, 2022 | 0.0245 |
| June 30, 2022 | 0.0258 |
| March 31, 2022 | 0.0247 |
| December 31, 2021 | 0.0235 |
| September 30, 2021 | 0.0223 |
| June 30, 2021 | 0.0212 |
| March 31, 2021 | 0.0208 |
| December 31, 2020 | 0.022 |
| September 30, 2020 | 0.0219 |
| June 30, 2020 | 0.0222 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0231 |
| December 31, 2019 | 0.0235 |
| September 30, 2019 | 0.0223 |
| June 30, 2019 | 0.0219 |
| March 31, 2019 | 0.0212 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Encompass Health Corp. | 1.094 |
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| U.S. Stem Cell, Inc. | -- |
| Marijuana, Inc. | 0.0038 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 182.76M |
| Total Liabilities (Quarterly) | 19.50M |
| Shareholders Equity (Quarterly) | 163.26M |
| Current Ratio | 9.657 |
| Net Debt Paydown Yield | -0.06% |